Knowledge, Attitudes and Associated Factors Surrounding COVID-19 Vaccination

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".

Deadline for manuscript submissions: 31 May 2024 | Viewed by 1611

Special Issue Editor


E-Mail Website
Guest Editor
1. School of Psychology, Swansea University, Swansea, UK
2. Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
Interests: COVID-19 vaccine

Special Issue Information

Dear Colleagues,

This Special Issue will explore a range of factors associated with attitudes, intentions and decisions related to COVID-19 vaccinations. It will include international perspectives and multiple methodological approaches (quantitative and/or qualitative) in order to improve our knowledge of the determinants of vaccine hesitancy and acceptance around COVID-19 vaccination. It will include research that draws from a range of theoretical insights and frameworks (e.g., the Behavioural and Social Drivers (BeSD) of vaccination). Submissions may also explore the topic of misinformation and the ‘infodemic’ related to COVID-19 vaccines. Submissions that are novel and extend the growing literature on this topic are particularly encouraged, including large multi-country studies and longitudinal analyses. Studies looking at attitudes and behaviours related to ongoing COVID-19 vaccination hesitancy or acceptance (including the relation between attitudes to COVID-19 vaccines and other vaccinations such as flu vaccinations and childhood immunizations) are also welcome. Although the COVID-19 pandemic is no longer a global emergency, this Special Issue will build upon the global evidence base by improving our knowledge of how people make decisions around vaccination, including the enablers and barriers, and focusing on lessons learned from the past three years.

We appreciate your consideration, and sincerely hope you will participate.

Kind regards,
Dr. Simon Nicholas Williams
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • attitudes
  • knowledge
  • vaccine hesitancy
  • COVID-19 vaccines
  • behaviours

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 982 KiB  
Article
Knowledge, Attitudes, and Practices on COVID-19 Vaccination among General Adult Population in Malawi: A Countrywide Cross-Sectional Survey
by Master R. O. Chisale, Dzinkambani Kambalame, Saul Eric Mwale, Balwani Chingatichifwe Mbakaya, Regina Mankhamba, Pizga Kumwenda, Ben Chilima, Collins Mitambo, Mavuto Chiwaula, Billy Nyambalo, Clara Sambani, Jellita Gondwe, Charity Muwalo, Amon Dembo, Lines Chinyamunyamu, Mavuto Thomas, Matthews Kagoli and Evelyn Chitsa Banda
Vaccines 2024, 12(3), 221; https://doi.org/10.3390/vaccines12030221 - 20 Feb 2024
Viewed by 1253
Abstract
Vaccination is one of the essential measures in reducing transmission, morbidity, and mortality rates of a disease. However, the COVID-19 vaccination is facing hesitancy across the globe, Malawi included. A population-based cross-sectional study was conducted in Malawi to document knowledge, attitudes, and practices [...] Read more.
Vaccination is one of the essential measures in reducing transmission, morbidity, and mortality rates of a disease. However, the COVID-19 vaccination is facing hesitancy across the globe, Malawi included. A population-based cross-sectional study was conducted in Malawi to document knowledge, attitudes, and practices on COVID-19 vaccination. The study targeted the general adult population and employed a multi-stage sampling technique. The Census Enumeration Areas within the 16 selected districts served as a primary sampling unit. Among the total 3068 participants, 1947 (63.6%) were female. About 1039 (34.1%) participants had primary education, while only 169 (5.5%) had college education. A total of 2936 (95.7%) participants knew about the COVID-19 vaccine, and 2063 (68.4%) felt that the COVID-19 vaccine was effective. A total of 1180 (38.7%) got vaccinated. Knowledge of the COVID-19 vaccination was significantly associated with participants’ education levels, location, occupation, marital status, household family income, and whether they were suffering from chronic illness or not. Overall, the level of knowledge and attitudes about the COVID-19 vaccination was good. This study has also established that different population groups have statistically different levels of knowledge and attitudes regarding COVID-19 vaccination. This study has also indicated a significant relationship between the rate of vaccination and several factors. Therefore, this calls for stakeholders to continue awareness and group-targeted tailored campaigns so as to increase COVID-19 vaccination. Full article
Show Figures

Figure 1

Back to TopTop